ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Irinotecan Fresenius 300 mg/15 ml, Infusionskonzentrat - 
61246019 Fresenius Kabi (Schweiz) AG
Irinotecan Fresenius 300 mg/15 ml, Infusionskonzentrat28.01.2011
Generic28.01.2011
Irinotecan (L01CE02) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
245.64No
    
10 %283.55
  
7680612460190Synthetika
7738397 
Composition
irinotecani hydrochloridum trihydricum 300 mg, sorbitolum, acidum lacticum, aqua ad iniectabile q.s. ad solutionem pro 15 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Irinotecan Hydrochloride Trihydrate300mg / 15ml
BAG: Active AgentDose
Irinotecan Hydrochloride Trihydrate300 mg
 
Inactive agents
Lactic Acid
Sorbitol
 
Source
Data was imported : 06.08.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home